Limiting Hepatitis C Virus (HCV) Progression in Liver Transplant Recipients Using Sirolimus Based Immunosuppression

被引：0
|
作者：
McKenna, Greg J. [1 ]
Trotter, James [1 ]
Klintmalm, Erik [1 ]
Chinnakotla, Srinath [1 ]
Randall, Henry [1 ]
Onaca, Nicholas [1 ]
Ruiz, Richard [1 ]
Levy, Marlon F. [1 ]
Goldstein, Robert M. [1 ]
Klintmalm, Goran B. [1 ]
机构：
[1] Baylor Reg Transplant Inst, Dallas, TX USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2010年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [31] Multicentric outcome analysis of sirolimus-based immunosuppression in 252 liver transplant recipients
    Molinari, Michele
    Berman, Kenneth
    Meeberg, Glenda
    Shapiro, James A.
    Bigam, David
    Trotter, James F.
    Kneteman, Norman
    TRANSPLANT INTERNATIONAL, 2010, 23 (02) : 155 - 168
  • [32] Immunosuppression in HCV-positive liver-transplant recipients
    Chan, Aaron James
    Lake, John R.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (06) : 648 - 654
  • [33] IMMUNOSUPPRESSION IN HCV-RNA POSITIVE LIVER TRANSPLANT RECIPIENTS
    Yaroshenko, Ekaterina B.
    Kornilov, Maxim N.
    Miloserdov, Igor A.
    Moysyuk, Yan G.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 256 - 256
  • [34] The challenge of recurrent hepatitis C virus in liver transplant recipients
    Marotta, Paul J.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 18 : 19C - 26C
  • [35] SURVIVAL AND PROGRESSION OF FIBROSIS IN HISPANIC AND NON-HISPANIC LIVER TRANSPLANT (LT) RECIPIENTS WITH HEPATITIS C (HCV)
    Verna, Elizabeth C.
    Valadao, Rosa M.
    Farrand, Erica
    Pichardo, Elsa
    Lai, Jennifer C.
    Terrault, Norah
    Brown, Robert S.
    HEPATOLOGY, 2009, 50 (04) : 550A - 550A
  • [36] Post-Liver Transplant Fibrosis Progression Varies by Hepatitis C Virus (HCV) Genotype.
    Campos-Varela, Isabel
    Lai, Jennifer C.
    Verna, Elizabeth C.
    O'Leary, Jacqueline G.
    Stravitz, R. Todd
    Forman, Lisa M.
    Trotter, James F.
    Brown, Robert S.
    Terrault, Norah A.
    LIVER TRANSPLANTATION, 2014, 20 : S122 - S122
  • [37] Selection of immunosuppression in hepatitis C virus liver transplant recipients prevents biopsy-proven acute rejection
    Kim, Jong Man
    Lee, Kwang-Woong
    Song, Gi-Won
    Jung, Bo-Hyun
    Lee, Hae-Won
    Yi, Nam-Joon
    DavidKwon, Choon Hyuck
    Hwang, Shin
    Suh, Kyung-Suk
    Joh, Jae-Won
    Lee, Suk-Koo
    Lee, Sung-Gyu
    TRANSPLANTATION, 2016, 100 (07) : S514 - S514
  • [38] Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: An analysis of the Scientific Registry of Transplant Recipients Database
    Watt, Kymberly D.
    Dierkhising, Ross
    Heimbach, Julie K.
    Charlton, Michael R.
    LIVER TRANSPLANTATION, 2012, 18 (09) : 1029 - 1036
  • [39] Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: Association with rejection and increased immunosuppression after transplantation
    Singh, N
    Gayowski, T
    Ndimbie, OK
    Nedjar, S
    Wagener, MM
    Yu, VL
    SURGERY, 1996, 119 (04) : 452 - 456
  • [40] SURVIVAL AND RISK OF SEVERE HEPATITIS C VIRUS (HCV) RECURRENCE IN LIVER TRANSPLANT (LT) RECIPIENTS COINFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND HCV
    Terrault, Norah
    Barin, Burc
    Schiano, Thomas D.
    Poordad, Fred
    Wong, Michael
    de Vera, Michael E.
    Simon, David
    Rosenthal, Lori
    Jayaweera, Dushyantha
    Johnson, Lynt B.
    Olthoff, Kim M.
    Stosor, Valentina Stosor
    Sherman, Kenneth E.
    Eghtesad, Bijan
    Harland, Robert
    Regenstein, Fredric
    Hamilton, James P.
    Pruett, Timothy L.
    Roland, Michelle
    Stock, Peter
    HEPATOLOGY, 2009, 50 (04) : 396A - 396A
12345